Piramal Pharma Q3 Results
- BSE: 543635
- NSE: PPLPHARMA
- ISIN: INE0DK501011
- Sector: -
BSE
249.75
-0.15 (-0.06%)
-0.15 (-0.06%)Volume2.52 L
Updated: Mon 25 Nov, 2024 | 15:29:47
NSE
250.3
0.15 (0.06%)
0.15 (0.06%)Volume4.05 M
Updated: Mon 25 Nov, 2024 | 15:41:45
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Piramal Pharma Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp |
|---|---|---|---|
| Total Revenue | 1,958.57 | 1,911.38 | -% |
| Selling/ General/ Admin Expenses Total | 523.78 | 516.03 | -% |
| Depreciation/ Amortization | 186.32 | 184.51 | -% |
| Other Operating Expenses Total | -61.51 | -49.19 | -% |
| Total Operating Expense | 1,356.01 | 1,289.08 | -% |
| Operating Income | 602.56 | 622.30 | -% |
| Net Income Before Taxes | 19.36 | 39.56 | -% |
| Net Income | 10.11 | 5.02 | -% |
| Diluted Normalized EPS | 0.21 | 0.04 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST